9 December 2024
Expanding access to the weight loss drug tirzepatide
The recent announcement from NICE means patients will be able to access tirzepatide (also known as Mounjaro), where clinically appropriate, within 90 days of NICE's final guidance being published for specialist weight management services and 180 days in primary care.
Final guidance is expected to be published on 23 December 2024.
NHS NW London will be working with NHS England and its providers across the sector to implement NICE recommendations. Further updates will be provided in the new year.
NHS England has released a FAQ document with details on the rollout of tirzepatide (Mounjaro) across the NHS.